Senate LDA lobbying filing
PFIZER INC.
Reported income
not reported
Reported expenses
$970.0K
Tracked program mentions4
Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.
S723/HR1458 - Access to Prescription Digital Therapeutics Act HR8816 - American Medical Innovation and Investment Act…
- Chemical and Biological Weapons Elimination Technology Improvement0607162D8Zmatched: “Elimination|Improvement”matched 2+ title words
VICP Reform and Excise Tax Inflation Reduction Act (IRA) HR7174 - Ensuring Pathways to Innovative Cures (EPIC) Act…
- Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
International Supply Chain HR4307/S2115 - Medical Supply Chain Resiliency Act
VICP Reform and Excise Tax Inflation Reduction Act (IRA) HR7174 - Ensuring Pathways to Innovative Cures (EPIC) Act…
Lobbying activities4
Health IssuesHCR
VICP Reform and Excise Tax Inflation Reduction Act (IRA) HR7174 - Ensuring Pathways to Innovative Cures (EPIC) Act Medicare Price Setting Part D Payer Utilization Management Drug Shortages S2916 - Prescription Information Modernization Act of 2023 Vaccines, Clinical Trials and Coverage S2305 - Biosimilar Red Tape Elimination Act Biosimilar Access and Interchangeability HR 2666 - Medicaid Value Based Payments for Patients (MVP) Act HR 4758 - Accelerating Kids Access to Care Act HR 7384 - Rare Pediatric Disease Priority Review (PRV) Voucher Trade-Related Aspects of Intellectual Property Rights March-in Framework Guidance and Policies S.79 - Interagency Patent Coordination and Improvement Act of 2023 S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.150 - Affordable Prescriptions for Patients Act of 2023 S.2780 - Medication Affordability and Patent Integrity Act Digital: Data Flows and Digital Trade
Medicare/MedicaidMMM
S723/HR1458 - Access to Prescription Digital Therapeutics Act HR8816 - American Medical Innovation and Investment Act of 2024 PBM Transparency and Reform S1542/HR6283 - Delinking Revenue from Unfair Gouging (DRUG) Act HR2880 - Protecting Patients Against PBM Abuses Act HR5378 - Lower Costs More Transparency Act 340B Reform HR8574 - 340B Affording Care for Communities and Ensuring a Strong Safety-net (ACCESS) Act
Taxation/Internal Revenue CodeTAX
Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act (TCJA) VICP Reform and Excise Tax VICP Transition Comprehensive Federal Tax Reform
Trade (domestic/foreign)TRD
International Supply Chain HR4307/S2115 - Medical Supply Chain Resiliency Act
Lobbyists8
- ANGELA WILES
- ELISSA ALBEN
- EMILY MUELLER
- FRANCISCO CARRILLO
- JENNIFER WALTON
- MATTHEW STROIA
- PAULA BURG
- STEPHEN CLAEYS
Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.